Shuo-Fu Chen, Liang-Yun Wang, Yi-Sian Lin, & Cho-Yi Chen. (2024). Novel protein-based prognostic signature linked to immunotherapeutic efficiency in ovarian cancer. BMC.
Chicago Style (17th ed.) CitationShuo-Fu Chen, Liang-Yun Wang, Yi-Sian Lin, and Cho-Yi Chen. Novel Protein-based Prognostic Signature Linked to Immunotherapeutic Efficiency in Ovarian Cancer. BMC, 2024.
MLA (9th ed.) CitationShuo-Fu Chen, et al. Novel Protein-based Prognostic Signature Linked to Immunotherapeutic Efficiency in Ovarian Cancer. BMC, 2024.
Warning: These citations may not always be 100% accurate.